Penumbra (NYSE:PEN) EVP Sells $90,039.00 in Stock

Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts sold 300 shares of the company’s stock in a transaction that occurred on Friday, December 5th. The shares were sold at an average price of $300.13, for a total value of $90,039.00. Following the sale, the executive vice president directly owned 63,836 shares in the company, valued at approximately $19,159,098.68. This represents a 0.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Johanna Roberts also recently made the following trade(s):

• On Monday, December 1st, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $294.94, for a total value of $176,964.00.
• On Tuesday, November 25th, Johanna Roberts sold 1,800 shares of Penumbra stock. The shares were sold at an average price of $300.06, for a total transaction of $540,108.00.
• On Monday, November 10th, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $266.98, for a total transaction of $160,188.00.
• On Wednesday, October 1st, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $249.70, for a total transaction of $149,820.00.

Penumbra Stock Performance

Penumbra stock traded down $7.72 during midday trading on Tuesday, reaching $287.11. 551,940 shares of the stock traded hands, compared to its average volume of 452,942. Penumbra, Inc. has a fifty-two week low of $221.26 and a fifty-two week high of $310.00. The company has a current ratio of 6.73, a quick ratio of 4.18 and a debt-to-equity ratio of 0.02. The firm has a market cap of $11.24 billion, a price-to-earnings ratio of 68.69, a PEG ratio of 2.43 and a beta of 0.66. The firm has a fifty day moving average price of $265.68 and a two-hundred day moving average price of $258.25.

Penumbra (NYSE:PEN) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.07. The business had revenue of $354.69 million during the quarter, compared to the consensus estimate of $340.77 million. Penumbra had a return on equity of 11.35% and a net margin of 12.30%.The business’s revenue was up 17.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.85 earnings per share. On average, equities research analysts forecast that Penumbra, Inc. will post 3.67 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have commented on PEN. BTIG Research restated a “buy” rating and set a $320.00 price target on shares of Penumbra in a research report on Monday, October 27th. Weiss Ratings reissued a “hold (c+)” rating on shares of Penumbra in a report on Tuesday, November 25th. Needham & Company LLC reaffirmed a “buy” rating and set a $326.00 price target on shares of Penumbra in a research note on Monday, October 27th. Wall Street Zen lowered Penumbra from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Finally, Wells Fargo & Company started coverage on shares of Penumbra in a research report on Tuesday, November 18th. They issued an “underweight” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $305.69.

Institutional Trading of Penumbra

Several large investors have recently modified their holdings of the stock. Invesco Ltd. grew its holdings in shares of Penumbra by 1,139.3% during the second quarter. Invesco Ltd. now owns 633,485 shares of the company’s stock worth $162,571,000 after purchasing an additional 582,369 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in Penumbra by 437.0% during the 1st quarter. JPMorgan Chase & Co. now owns 703,634 shares of the company’s stock worth $188,159,000 after acquiring an additional 572,606 shares during the last quarter. Norges Bank bought a new stake in Penumbra during the 2nd quarter worth approximately $114,014,000. Holocene Advisors LP acquired a new position in Penumbra in the 3rd quarter valued at approximately $78,585,000. Finally, Lord Abbett & CO. LLC bought a new position in shares of Penumbra during the first quarter valued at $63,731,000. 88.88% of the stock is owned by institutional investors and hedge funds.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.